STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Effect of Vitamin D Supplementation on Inflammation and Cardiometabolic Risk Factors in Obese Adolescents

Not Applicable

Completed

Conditions: Obesity

Interventions: Drug: Drisdol (Ergocalciferol) Vitamin D2
Drug: Placebo

First Posted Date: 2010-10-08

Last Posted Date: 2017-11-29

Lead Sponsor: Stanford University

Target Recruit Count: 40

Registration Number: NCT01217840

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Implantable Cardioverter-Defibrillator Use in the VA System

Phase 3

Completed

Conditions: Cardiomyopathies

Interventions: Behavioral: Clinical Reminder

First Posted Date: 2010-10-08

Last Posted Date: 2021-05-19

Lead Sponsor: Stanford University

Target Recruit Count: 89

Registration Number: NCT01217827

Locations: 🇺🇸
VA Palo Alto Health Care System, Palo Alto, California, United States
🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Teaching Math Skills to Individuals With Fragile X Syndrome

Not Applicable

Completed

Conditions: Developmental Disabilities
Fragile X Syndrome

Interventions: Behavioral: discrete-trial training

First Posted Date: 2010-09-17

Last Posted Date: 2019-05-09

Lead Sponsor: Stanford University

Target Recruit Count: 60

Registration Number: NCT01204151

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

Phase 2

Withdrawn

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Placebo
Drug: Apremilast

First Posted Date: 2010-09-17

Last Posted Date: 2016-02-05

Lead Sponsor: Stanford University

Registration Number: NCT01204138

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

Completed

Conditions: Tendinopathy
Rheumatic Diseases

First Posted Date: 2010-09-14

Last Posted Date: 2018-08-06

Lead Sponsor: Stanford University

Target Recruit Count: 25

Registration Number: NCT01200875

Locations: 🇺🇸
New York University Langone Orthopedic Hospital, New York, New York, United States

Controlled Ventilation CT in CF Infants

Terminated

Conditions: Cystic Fibrosis

First Posted Date: 2010-09-14

Last Posted Date: 2018-04-23

Lead Sponsor: Stanford University

Target Recruit Count: 1

Registration Number: NCT01200888

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Not Applicable

Terminated

Conditions: Lung Cancer Small Cell Lung Cancer (SCLC)
Lung Cancer Non-Small Cell Cancer (NSCLC)
Lung Cancer
Mesothelioma

Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT)
Radiation: Computed Tomography (CT)
Device: Cyberknife
Device: Trilogy
Device: True Beam
Drug: Iohexol
Drug: Iodixanol

First Posted Date: 2010-08-25

Last Posted Date: 2018-04-17

Lead Sponsor: Stanford University

Target Recruit Count: 12

Registration Number: NCT01188486

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides

Phase 1

Terminated

Conditions: Cutaneous Lymphoma
Cutaneous T-cell Lymphoma

Interventions: Radiation: Total skin electron beam therapy (TSEBT)
Drug: Vorinostat

First Posted Date: 2010-08-24

Last Posted Date: 2017-11-20

Lead Sponsor: Stanford University

Target Recruit Count: 28

Registration Number: NCT01187446

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes

Not Applicable

Completed

Conditions: Kidney Failure, Chronic

Interventions: Dietary Supplement: Corn starch
Dietary Supplement: Fiber

First Posted Date: 2010-08-23

Last Posted Date: 2022-08-25

Lead Sponsor: Stanford University

Target Recruit Count: 58

Registration Number: NCT01186276

Locations: 🇺🇸
VA Palo Alto Health Care System, Palo Alto, California, United States
🇺🇸
Satellite Dialysis, Redwood City, California, United States
🇺🇸
SCVMC, San Jose, California, United States

Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation

Phase 2

Completed

Conditions: Cardiac Allograft Vasculopathy

Interventions: Drug: Pioglitazone
Drug: Placebo

First Posted Date: 2010-08-23

Last Posted Date: 2016-08-18

Lead Sponsor: Stanford University

Target Recruit Count: 18

Registration Number: NCT01186250

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy